Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-27

Clinical Trial Update: Long-term Safety and Effectiveness of Levodopa-carbidopa Intestinal Gel Infusion

View source ↗

Summary

An update on the long-term safety and effectiveness of Levodopa-carbidopa intestinal gel infusion for Parkinson disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levodopa-carbidopa intestinal gel infusion (levodopa-carbidopa intestinal gel infusion)

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Parkinson Disease | Status: UNKNOWN